Additionally, since SMAD4 by itself is frequently mutated and inactivated in colon cancer [16], it is important to understand the SMAD-independent signaling of activin and TGFβ and the downstream impact on metastatic processes. Here, SMAD4 is linked to malignant colon neoplasm.